Development of the infants given tadalafil treatment in utero.
Not Applicable
Recruiting
- Conditions
- Fetal growth restriction and hypertensive pregnancy disorders
- Registration Number
- JPRN-UMIN000028773
- Lead Sponsor
- Mie university hospital, Department of Obstetrics and Gynecology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Written informed consent
Exclusion Criteria
Attending physician decides to entry inappropriate.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Ratio of the infants with less than 70 of DQ score.
- Secondary Outcome Measures
Name Time Method 1. Effect of tadalafil treatment on DQ score.<br>2. Effect of maternal complications on ratio of the infants with less than 70 of DQ score.<br>3. Effect of maternal complications on DQ score.<br>4. Effect of perinatal factors on ratio of the infants with less than 70 of DQ score.<br>5. Effect of perinatal factors on DQ score.